|
|
|
|
>>您当前所在的位置：
首页 学科服务 ESI学科快报
|
科睿唯安（Clarivate Analytics，原汤森路透）2019年3月14日发布的ESI最新数据显示（数据覆盖时间范围为2008年1月1日-2018年12月31日），本期全球共有6009个机构登上ESI榜单，我校位于第2143位。我校临床医学学科在该学科上榜的全球4287个机构中，排名第1287位，学科百分比排名为30.02%。 一、我校ESI学科建设概况 1.我校ESI学科基本情况 表1 我校ESI总体排名情况 机构名称 | 总机构数 | 排名 | 百分比排名 | WoS论文数 | 被引频次 | 篇均被引频次 | 高水平论文 | 高被引论文 | 热点论文 | 福建医科大学 | 6009 | 2143 | 35.66% | 5631 | 41863 | 7.43 | 15 | 15 | 1 |
表2 我校ESI学科排名情况 学科 | 总机构数 | 排名 | 百分比排名 | WoS论文数 | 被引频次 | 篇均被引频次 | 高水平论文 | 高被引论文 | 热点论文 | 临床医学 | 4287 | 1287 | 30.20% | 2962 | 19904 | 6.72 | 9 | 9 | 1 |
2.我校ESI潜力学科基本情况 目前，我校18个ESI潜力学科中，潜力值位于前三的学科分别是：化学（0.659）、药理学与毒理学（0.623）、神经科学与行为学（0.537），各学科潜力值如下图： 
图1 我校ESI学科潜力值基本情况 二、我校高水平论文基本情况 本期我校共有15篇高水平论文，其中高被引论文9篇，热点论文1篇。高水平论文学科分布情况为：临床医学9篇（其中1篇同时为高被引论文和热点论文）、材料科学1篇、分子生物学和遗传学1篇、神经科学与行为学1篇、化学1篇、物理学1篇、药理学与毒理学1篇。高水平论文基本情况如下表： 表3 我校高水平论文概览 序号 | 我校作者 | 文章题名 | 学科 | 被引次数 | 出处 | 1 | Yang, LY (Yang, Liyong) ; Yan, SJ (Yan, Sunjie) | Effect Of Intensive Insulin Therapy On Beta-cell Function And Glycaemic Control In Patients With Newly Diagnosed Type 2 Diabetes: A Multicentre Randomised Parallel-group Trial | 临床医学 | 363 | LANCET,2008,371(9626): 1753-1760 | 2 | Li, L (Li, Li); Li, HF (Li, Haifu); Sheng, XN (Sheng, Xinan); Cui, CL (Cui, Chuanliang); Chi, ZH (Chi, Zhihong); Li, SM (Li, Siming); Han, M (Han, Mei); Mao, LL (Mao, Lili); Lin, XD (Lin, Xuede) | Phase Ii, Open-label, Single-arm Trial Of Imatinib Mesylate In Patients With Metastatic Melanoma Harboring C-kit Mutation Or Amplification | 临床医学 | 287 | J CLIN ONCOL,2011,29 (21): 2904-2909 | 3 | Lin, XY (Lin, Xiaoyan) | Randomized, Double-blind, Placebo-controlled Phase Iii Trial Of Apatinib In Patients With Chemotherapy-refractory Advanced Or Metastatic Adenocarcinoma Of The Stomach Or Gastroesophageal Junction | 临床医学 | 200 | J CLIN ONCOL,2016,34 (13): 1448-+ | 4 | Bruijn, SM (Bruijn, S. M.); Meijer, OG (Meijer, O. G.) | Assessing The Stability Of Human Locomotion: A Review Of Current Measures | 临床医学 | 130 | J R SOC INTERFACE 2013,10 (83) | 5 | Zhang, D (Zhang, Da) ; Wu, M (Wu, Ming) ; Zeng, YY (Zeng, Yongyi) ; Wu, LJ (Wu, Lingjie); Wang, QT (Wang, Qingtang) ; Liu, XL (Liu, Xiaolong) ; Liu, JF (Liu, Jingfeng) | Chlorin E6 Conjugated Poly(dopamine) Nanospheres As Pdt/ptt Dual-modal Therapeutic Agents For Enhanced Cancer Therapy | 材料科学 | 110 | ACS APPL MATER INTERFACES,2015,7 (15): 8176-8187 | 6 | Huang, CM (Huang,Changming); Zheng, CH (Zheng, Chaohui); Li, P (Li, Ping) | Morbidity And Mortality Of Laparoscopic Versus Open D2 Distal Gastrectomy For Advanced Gastric Cancer: A Randomized Controlled Trial | 临床医学 | 88 | J CLIN ONCOL,2016,34 (12): 1350-+ | 7 | Ren, MX (Ren, Meixia） | Genome-wide Association Analysis Identifies Novel Blood Pressure Loci And Offers Biological Insights Into Cardiovascular Risk | 分子生物学与遗传学 | 72 | NAT GENET,2017,49 (3): 403-415 | 8 | Chen, C (Chen, Chun) | Gefitinib Versus Vinorelbine Plus Cisplatin As Adjuvant Treatment For Stage Ii-iiia (n1-n2) Egfr-mutant Nsclc (adjuvant/ctong1104): A Randomised, Open-label, Phase 3 Study | 临床医学 | 43 | LANCET ONCOL,2018,19 (1): 139-148 | 9 | Wu, XL (Wu, Xilin); Chen, XC (Chen, Xiaochun) | Trem2 Is A Receptor For Beta-amyloid That Mediates Microglial Function | 神经科学与行为学 | 25 | NEURON,2018,97 (5): 1023-+ | 10 | Zeng, YY (Zeng, Yongyi) | Trem2 Is A Receptor For Beta-amyloid That Mediates Microglial Function | 化学 | 18 | ANAL CHEM,2018,90 (11): 7086-7093 | 11 | Fu, J (Fu, Jing) | Precision Diagnosis And Treatment Of Liver Cancer In China | 临床医学 | 13 | CANCER LETT,2018,412: 283-288 | 12 | Pan, JJ (Pan, Jian Ji) | International Guideline For The Delineation Of The Clinical Target Volumes (ctv) For Nasopharyngeal Carcinoma | 临床医学 | 12 | RADIOTHER ONCOL,2018, 126 (1): 25-36 | 13 | Zhang, D (Zhang, Da); Wu, M (Wu, Ming); Cai, ZX (Cai, Zhixiong); Liao, NS (Liao, Naishun); Ke, K (Ke, Kun); Liu, HZ (Liu, Hongzhi); Li, M (Li, Ming); Liu, XL (Liu, Xiaolong); Liu, JF (Liu, Jingfeng) | Chemotherapeutic Drug Based Metal-organic Particles For Microvesicle-mediated Deep Penetration And Programmable Ph/nir/hypoxia Activated Cancer Photochemotherapy | 物理学 | 10 | ADVANCED SCI,2018, 5 (2) | 14 | (Huang, Jiaming) | Epidemiology Of Carbapenem-resistant Enterobacteriaceae Infections: Report From The China Cre Network | 药理学与毒理学 | 8 | ANTIMICROB AGENTS CHEMOTHER,2018, 62 (2) | 15 | Shi, CM (Shi, Chunmei) | Results Of A Randomized, Double- Blind, Placebo- Controlled, Phase Iii Trial Of Trifluridine/tipiracil (tas-102) Monotherapy In Asian Patients With Previously Treated Metastatic Colorectal Cancer: The Terra Study | 临床医学 | 8 | J CLIN ONCOL,2018,36 (4): 350-+ | 注：此表作者仅体现第一署名单位为“福建医科大学”的本校作者。 | |
|
|
|
